510(k) Report

510(k) · Cleared

Cleared

8-CH Electroencephalography Amplifier

K201747510(k) TraditionalCleared Dec 27, 2020184-day reviewClass II21 CFR 882.1835

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hipposcreen Neurotech Corp. · GWL Amplifier, Physiological Signal

Cleared on Dec 27, 2020 as substantially equivalent to K172312 (Eemagine Medical Imaging Solutions GmbH, 2018) after a 184-day review. Its family tree reaches back 2 generations to 2006.

Decided
Dec 27, 2020
Review
184 days
Class
Class II
Product code
GWL
Recalls
None
Predicates
1

Its longest line of descent runs back 2 generations to K060374 (2006). No later device cites it as a predicate yet.

  1. Root · 2 generations backK060374 Refa, Physiological AmplifierTms International BV · 2006
  2. 1 generation backK172312 eego amplifiersEemagine Medical Imaging Solutions GmbH · 2018
  3. This deviceK201747 8-CH Electroencephalography AmplifierHipposcreen Neurotech Corp. · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K060374Refa, Physiological AmplifierTms International BV2006—
−1K172312eego amplifiersEemagine Medical Imaging Solutions GmbH2018—
0 (this device)K2017478-CH Electroencephalography AmplifierHipposcreen Neurotech Corp.2020—
FIG. 1 — Lineage of K201747, 2006–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in GWL? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new GWL device

  1. #1 K232210 X-trodes System Mscore 10.4 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K172312eego amplifiers
Summary page 6
…hy Amplifier 510 (k) Summary Device Class: II 510(k) Number: K172312 6 Intended Use Used to electrically amplify signals derived from electroencephalogram. 7 Indications for Use of the Devi…
Eemagine Medical Imaging Solutions GmbH2018—

Also cleared against K172312: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 11.8 years on median.
  • None of the 2 ancestors has a recall.
  • 1 other device also cites its predicate K172312.

How does its category compare?

All GWL devices

GWL Amplifier, Physiological Signal: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · GWL

1in 2025

2007: 12009: 22010: 12011: 12012: 22014: 12015: 12017: 22018: 12020: 12021: 22022: 12023: 22024: 42025: 1
2007high 4 (2024) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · GWL

133in 2024

2024: 133 days median
2007high 133 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · GWL

1in 2013

2010: 12013: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · GWL

1in 2018

2008: 22018: 1
2007high 2 (2008) · low 0 (2007)2025

MAUDE reports naming product code GWL, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—02
20092—00
20101—10
20111—00
20122—00
20130—10
20141—00
20151—00
20160—00
20172—00
20181—01
20190—00
20201—00
20212—00
20221—00
20232—00
2024413300
20251—00
20260—0—

What is it indicated for?

The 8-CH Electroencephalography Amplifier is intended to be used by or under the direction of a physician for acquisition of EEG signals, to transmit them digitally to a computer, and display waveform in real-time. The device is intended for use on humans. The device is intended for use in a clinical environment (e.g., hospital, physician’s office, etc). The device is not intended for use in life support systems.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K201747: 8-CH Electroencephalography Amplifier.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K201747

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026